<DOC>
	<DOCNO>NCT02133781</DOCNO>
	<brief_summary>This exploratory study use strategy previously employ investigate effect age vaccine type specific kind immune response license , seasonal 2009-2010 influenza vaccine child adult .</brief_summary>
	<brief_title>B-cell Immunity Influenza ( SLVP017 ) - Year 1 , 2009</brief_title>
	<detailed_description>This study conduct healthy male female volunteer . 8-17 year-old identical twin randomly assign receive single administration 2009-2010 formulation either seasonal trivalent inactivate influenza vaccine ( TIV ) live , attenuated influenza vaccine ( LAIV ) . Twins within pair receive different vaccine . 18-30 year-old 70-100 year-old subject receive single administration 2009-2010 formulation TIV . Blood sample conduct assay take pre-immunization , Day 7-8 Day 28 post immunization .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Otherwise healthy , ambulatory child 817 yearold twin , adult 1830 year old ( nontwin ) 70100 yearold elderly nontwin adult . Willing complete informed consent process . Availability followup plan duration study least 28 day immunization . Acceptable medical history medical history vital sign . Prior offstudy vaccination current seasonal TIV LAIV Fall 2009 Allergy egg egg product , vaccine component , include gentamicin , gelatin , arginine MSG ( LAIV ) , thimerosal ( TIV multidose vial ) . Lifethreatening reaction previous influenza vaccination Asthma history wheezing ( volunteer randomize LAIV ) Active systemic serious concurrent illness , include febrile illness day vaccination History immunodeficiency ( include HIV infection ) Known suspect impairment immunologic function , include , limited , clinically significant liver disease , diabetes mellitus treat insulin , moderate severe renal disease , chronic disorder , opinion investigator , might jeopardize volunteer safety compliance protocol . Blood pressure &gt; 150 systolic &gt; 95 diastolic first study visit Hospitalization past year congestive heart failure emphysema . Chronic Hepatitis B C. Recent current use immunosuppressive medication , include systemic glucocorticoid ( corticosteroid nasal spray topical steroid permissible group ; inhale steroid use permissible except nonLAIV Group ) . Use oral steroid ( &lt; 20 mg prednisoneequivalent/day ) may acceptable volunteer 70100 yrs age review investigator . Participants close contact anyone severely weaken immune system receive LAIV Malignancy , squamous cell basal cell skin cancer ( include solid tumor breast cancer prostate cancer recurrence past year , hematologic cancer leukemia ) . Autoimmune disease ( include rheumatoid arthritis treat immunosuppressive medication Plaquenil , methotrexate , prednisone , Enbrel ) , opinion investigator , might jeopardize volunteer safety compliance protocol . History blood dyscrasia , renal disease , hemoglobinopathies require regular medical follow hospitalization precede year Use anticoagulation medication Coumadin Lovenox , antiplatelet agent aspirin ( except 325 mg. per day ) , Plavix , Aggrenox must review investigator determine would affect volunteer 's safety . Receipt blood blood product within past 6 month Medical psychiatric condition occupational responsibility preclude participant compliance protocol Inactivated vaccine 14 day prior vaccination Live , attenuate vaccine within 60 day vaccination History GuillainBarr√© Syndrome Pregnant lactate woman Use investigational agent within 30 day prior enrollment Donation equivalent unit blood within 6 week prior enrollment Any condition , opinion investigator , might interfere volunteer safety , study objective ability participant understand comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inactivated influenza vaccine</keyword>
	<keyword>Live , attenuate influenza vaccine</keyword>
	<keyword>Child identical twin</keyword>
	<keyword>Young elderly adult</keyword>
</DOC>